These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28656061)

  • 1. Metabolomics Identifies Metabolic Markers of Maturation in Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Bhute VJ; Bao X; Dunn KK; Knutson KR; McCurry EC; Jin G; Lee WH; Lewis S; Ikeda A; Palecek SP
    Theranostics; 2017; 7(7):2078-2091. PubMed ID: 28656061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
    Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
    Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learn from Your Elders: Developmental Biology Lessons to Guide Maturation of Stem Cell-Derived Cardiomyocytes.
    Marchianò S; Bertero A; Murry CE
    Pediatr Cardiol; 2019 Oct; 40(7):1367-1387. PubMed ID: 31388700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo.
    Gomez-Garcia MJ; Quesnel E; Al-Attar R; Laskary AR; Laflamme MA
    Semin Cell Dev Biol; 2021 Oct; 118():163-171. PubMed ID: 34053865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic environment in vivo as a blueprint for differentiation and maturation of human stem cell-derived cardiomyocytes.
    Slaats RH; Schwach V; Passier R
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165881. PubMed ID: 32562698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
    Tan SH; Ye L
    J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
    Ban K; Bae S; Yoon YS
    Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics Method Enabled by Sequential Metabolomics and Proteomics for Human Pluripotent Stem-Cell-Derived Cardiomyocytes.
    Bayne EF; Simmons AD; Roberts DS; Zhu Y; Aballo TJ; Wancewicz B; Palecek SP; Ge Y
    J Proteome Res; 2021 Oct; 20(10):4646-4654. PubMed ID: 34499502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
    Lou X; Tang Y; Ye L; Pretorius D; Fast VG; Kahn-Krell AM; Zhang J; Zhang J; Qiao A; Qin G; Kamp T; Thomson JA; Zhang J
    Cardiovasc Res; 2023 May; 119(4):1062-1076. PubMed ID: 36647784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.
    Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM
    Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes.
    Wickramasinghe NM; Sachs D; Shewale B; Gonzalez DM; Dhanan-Krishnan P; Torre D; LaMarca E; Raimo S; Dariolli R; Serasinghe MN; Mayourian J; Sebra R; Beaumont K; Iyengar S; French DL; Hansen A; Eschenhagen T; Chipuk JE; Sobie EA; Jacobs A; Akbarian S; Ischiropoulos H; Ma'ayan A; Houten SM; Costa K; Dubois NC
    Cell Stem Cell; 2022 Apr; 29(4):559-576.e7. PubMed ID: 35325615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.
    Zhu R; Blazeski A; Poon E; Costa KD; Tung L; Boheler KR
    Stem Cell Res Ther; 2014 Oct; 5(5):117. PubMed ID: 25688759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Matured Human Pluripotent Stem Cell-Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts.
    Dhahri W; Sadikov Valdman T; Wilkinson D; Pereira E; Ceylan E; Andharia N; Qiang B; Masoudpour H; Wulkan F; Quesnel E; Jiang W; Funakoshi S; Mazine A; Gomez-Garcia MJ; Latifi N; Jiang Y; Huszti E; Simmons CA; Keller G; Laflamme MA
    Circulation; 2022 May; 145(18):1412-1426. PubMed ID: 35089805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes.
    Keung W; Boheler KR; Li RA
    Stem Cell Res Ther; 2014 Jan; 5(1):17. PubMed ID: 24467782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Aurora Kinase Inhibitor CYC116 Promotes the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
    Ji S; Tu W; Huang C; Chen Z; Ren X; He B; Ding X; Chen Y; Xie X
    Mol Cells; 2022 Dec; 45(12):923-934. PubMed ID: 36572561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor.
    Correia C; Christoffersson J; Tejedor S; El-Haou S; Matadamas-Guzman M; Nair S; Dönnes P; Musa G; Rohman M; Sundqvist M; Riddle RB; Nugraha B; Bellido IS; Johansson M; Wang QD; Hidalgo A; Jennbacken K; Synnergren J; Später D
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes.
    Correia C; Koshkin A; Duarte P; Hu D; Carido M; Sebastião MJ; Gomes-Alves P; Elliott DA; Domian IJ; Teixeira AP; Alves PM; Serra M
    Biotechnol Bioeng; 2018 Mar; 115(3):630-644. PubMed ID: 29178315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Oh J; Kwon OB; Park SW; Kim JW; Lee H; Kim YK; Choi EJ; Jung H; Choi DK; Oh BJ; Min SH
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes.
    Sun X; Nunes SS
    Methods; 2016 May; 101():21-6. PubMed ID: 26546730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.